EIGHT MODALITIES · ONE PLATFORM
From cell culture to chemical synthesis, the process stages, measurements and decisions change. BioMedAna connects that scientific context through Hub, Twin, Agents and OS.
SCIENTIFIC WORKFLOWS
Growth, metabolism, feeding, mass transfer, titer and CQAs.
Cell growth and viability
Culture kinetics and hybrid prediction
Compare media and feed strategies
Expression, purification, potency and product-quality attributes.
Host, expression conditions and induction
Expression and productivity relationships
Compare expression conditions
Starting-material variability, expansion, phenotype and potency.
Donor and material provenance
Expansion and variability analysis
Investigate donor and batch variability
Transfection, vector yield, capsid quality and robustness.
Cell line, seed train and reagent context
Production and process sensitivity
Compare transfection and harvest conditions
Substrate kinetics, OUR/OTR, feed, heat and productivity.
Strain, substrate and inoculum history
Growth and substrate-consumption kinetics
Compare feeding strategies
Synthesis, purification, impurities, yield and quality.
Synthesis cycles, reagents and material lots
Reaction efficiency and loss analysis
Investigate step-dependent yield losses
Reaction networks, dosing, conversion, selectivity, impurities and crystallization.
API product and route version
Stoichiometric and Arrhenius reaction kinetics
Compare temperature and dosing strategies
Cell-bank and seed-virus lineage, infection kinetics, harvest timing, recovery and inactivation evidence.
Cell-bank, seed-virus lot and passage genealogy
Data-driven titre trajectories with held-out run evaluation
Compare infection conditions and harvest windows
MODALITY ATLAS
Growth, metabolism, feeding, mass transfer, titer and CQAs.
Expression, purification, potency and product-quality attributes.
Starting-material variability, expansion, phenotype and potency.
Transfection, vector yield, capsid quality and robustness.
Substrate kinetics, OUR/OTR, feed, heat and productivity.
Synthesis, purification, impurities, yield and quality.
Reaction networks, dosing, conversion, selectivity, impurities and crystallization.
Cell-bank and seed-virus lineage, infection kinetics, harvest timing, recovery and inactivation evidence.
Model coverage and workflow configuration depend on the process, available evidence and intended decision. A modality name alone does not establish predictive performance; scope is agreed around your use case.
SHARED GOVERNANCE
Bio Hub preserves evidence and context. Bio Twin supports modeling and scenario comparison. Bio Agents coordinate analysis for expert review. Bio OS provides the shared governance and traceability foundation.